Baby Formula NEC Lawsuit

May 24, 2025 – Judge Upholds Plaintiffs’ Expert Testimony

In a significant ruling, Judge Rebecca Pallmeyer denied the defense’s Daubert motions seeking to exclude two key plaintiffs’ general causation experts in the NEC infant formula MDL. This decision preserves the plaintiffs’ core liability theory that cow’s milk–based formulas substantially increase the risk of necrotizing enterocolitis (NEC) in premature infants. The court rejected the defendants’ claims that the experts lacked qualifications or methodological rigor, allowing their testimony to proceed in upcoming trials.

May 5, 2025 – MDL Adds 27 New Cases

The NEC preterm infant formula MDL saw 27 new cases added in April—an increase from the 20 cases reported in March—bringing the total number of active lawsuits in the litigation to 710.

April 28, 2025 – Last Minute Discovery in Mar

The first NEC baby formula trial, Mar v. Abbott Laboratories, is scheduled to begin next week.  Plaintiffs recently disclosed that the former Executive Director of Mother’s Milk Bank Northeast will be a fact witness who will testify about the availability of donor milk as a safer alternative to cow’s milk-based formula. Abbott has moved to limit or exclude her testimony, claiming that her involvement is speculative because her milk bank did not previously supply the West Virginia hospital where the infant plaintiff was treated.

This testimony is helpful because it shows that safer alternatives to formula existed. That access to donor milk could have been pursued if families and physicians had been properly warned. The fact that no direct relationship existed between the Boston milk bank and the West Virginia hospital only highlights the failure of formula companies to adequately communicate the risks. With a proper warning, parents and providers could have explored donor milk sources instead of relying on formula that carries a known risk of NEC in premature infants.

April 27, 2025 – Plum Consumer Class Action Lawsuit Dismissed

The Ninth Circuit affirmed judgment for Plum PBC in a consumer protection case alleging the company failed to disclose that its baby food products could contain heavy metals and perchlorate. The court held that the plaintiffs did not allege that Plum’s products contained any specific or dangerous level of these substances, noting that heavy metals and perchlorate are commonly present in soil, air, and water.

The consumers brought claims under California consumer protection statutes following the 2021 House Oversight report on metals in baby food, but the Ninth Circuit found that even under any legal standard, Plum was entitled to summary judgment. The court also denied the plaintiffs’ request to certify a legal question to the California Supreme Court.

Remember, this was not a personal injury lawsuit like the claims we are bringing on behalf of children and families. This was a pure consumer deception case focused on labeling and marketing, without allegations of actual injury to children or families, and without seeking damages for personal harm.

April 1, 2025 – Plaintiffs Gain Traction as NEC Filings Drop to 20 in March

After a historic influx of 63 new cases in February, filings in the NEC baby formula MDL dropped to 20 in March. The total number of pending cases now stands at 683. This slowdown may not last. The first federal bellwether trial is just weeks away, and plaintiffs continue to gain traction with over half a billion dollars in verdicts across state courts. The recent reversal of the only defense win—thrown out for egregious trial conduct—has further energized families filing NEC claims nationwide.

March 3, 2025: 63 Cases Join MDL

In February, 63 new cases were added to the NEC preterm infant formula MDL, marking the highest monthly volume in some time. This brings the total number of pending cases to 663.

January 6, 2025: New Lawsuit Filed in the MDL

One those six lawsuits filed in the MDL last month was Roberts. v. Abbott. This wrongful death lawsuit alleges that A.R. developed necrotizing enterocolitis after being fed Abbott’s cow’s milk-based infant feeding products, including those marketed under the Similac brand. Born prematurely on July 16, 2001, at Winchester Hospital in Massachusetts, A.R. was fed these products shortly after birth. Days later, she was diagnosed with NEC, underwent surgery, and tragically passed away on July 27, 2001.

The family contends that Abbott’s products were unreasonably dangerous for premature infants, citing extensive scientific evidence linking cow’s milk-based formulas to an increased risk of NEC. The lawsuit also claims that Abbott failed to provide adequate warnings about these risks, despite being aware of the dangers. It further alleges that Abbott engaged in misleading marketing practices, portraying its products as safe and essential for infant growth while omitting critical safety information. The family seeks damages for the profound loss of A.R. and the emotional and financial impact of her passing..

November 1, 2024: Defense Verdict

Bad news in Whitfield yesterday. The jury found for the defendants. Also, 26 new cases were added to the NEC infant formula MDL in October, bringing the total to over 600 pending cases.

Yesterday’s loss in Missouri was a bit disheartening. That was not our case but based on what we know, we believe that child and and that family should have been compensated.  However, one loss will not slow down the newfound energy in this litigation.

October 7, 2024:  New Trial in Missouri

Opening statements were made in the new NEC baby formula trial, Whitfield v. St. Louis Children’s Hospital, in Missouri, with testimony expected to continue today.

This case is unique because, unlike many other NEC-related lawsuits that solely target the formula manufacturers, healthcare providers are also named as defendants. Typically, these lawsuits argue that formula manufacturers are at fault for failing to provide adequate warnings about the risks associated with cow-milk-based formulas for premature infants. However, this case shifts some of the focus onto the medical providers.

The argument against the healthcare providers is that they knew about the risks associated with feeding cow-milk-based formulas to vulnerable preterm infants and made the decision to administer it anyway, without informing the parents of the potential dangers.

The plaintiffs argue that if the medical staff was fully aware of these risks and chose to proceed without proper parental consent, they share liability for any harm caused. The manufacturers are responsible for placing warnings on their products. But doctors have an obligation to inform parents of the risks if they know them.

August 26, 2024: Parties Agree On Order Of First Four Bellwether Trials

The parties have agreed on the order of the first four bellwether trials, which are essentially test cases used to predict the outcome of similar cases in the larger litigation. Of course, we have already had two test cases that have led to nearly half a billion dollars in verdicts.

Instead of submitting separate arguments about the trial order, the parties have agreed to the following sequence:

1. Mar v. Abbott Laboratories
2. Diggs v. Abbott Laboratories
3. Etienne v. Abbott Laboratories
4. Inman v. Mead Johnson & Co.

The next upcoming status conference is set for Thursday.

August 9, 2024: Washington State Family Files New NEC Lawsuit In MDL 

A Washington state family filed a new NEC lawsuit in the MDL last week.

The complaint states that K.L. was born prematurely at 31 weeks gestation and was subsequently fed Abbott’s Similac Special Care formula while in the Neonatal Intensive Care Unit (NICU). Shortly after being fed the formula, K.L. developed NEC, leading to severe gastrointestinal complications, including intestinal rupturing, bowel problems, and the need for significant medical interventions. The plaintiffs argue that the formula directly caused these injuries.

July 27, 2024: Missouri Jury Awards $495 Million In Damages Against Abbott Laboratories 

A Missouri jury awarded $495 million in damages against Abbott Laboratories in the trial we discussed in our July 11 update below.

The jury awarded the plaintiff $400 million in punitive damages and $95 million in compensatory damages. The lawsuit claimed that Abbott failed to warn about the risks of NEC associated with its products, which are alleged to pose a significant threat to the health of preterm infants.

This case is among the second NEC baby formula lawsuits to go to trial.  One thing is for sure: the expected settlement compensation in these cases is a lot more today that it was yesterday.

July 11, 2024: New NEC Formula Trial Underway In Missouri State Court

A new NEC baby formula trial is underway in Missouri state court. This case is about a child who was born prematurely at SSM St. Mary’s Hospital in St. Louis, Missouri, on August 26, 2021. Shortly after birth, the child was transferred to Cardinal Glennon Children’s Hospital in the City of St. Louis, Missouri.

During the stay at Cardinal Glennon, the child was fed Similac and/or Enfamil cow’s milk-based products for the first time. After ingesting these products, the child developed necrotizing enterocolitis (NEC). As a result of the NEC diagnosis, the child was forced to undergo extensive surgery and has continued to suffer long-term health consequences throughout their life.

The outcome of this trial matters not only to the child and his family but to all other NEC formula plaintiffs.  These early verdicts will help form the settlements that victims see in  this litigation.

July 1, 2024: New NEC Lawsuit Filed In MDL 

Last week, a new lawsuit was filed in NEC MDL. The lawsuit was brought by the parents of M.N., a premature infant who tragically passed away after developing NEC. The plaintiffs allege that the condition was caused by cow’s milk-based products manufactured by Mead Johnson, including Enfamil Premature Infant Formula and Enfamil Care.

May 15, 2024: Court Enlists Third Party To Streamline Service of SFC To Counsel Of Record

To streamline the service of Short Form Complaints (SFC) to counsel of record and to ensure more accurate and transparent reporting for both parties, the court entered an order yesterday to enlist a third party, BrownGreer to implement specific protocol outlined in the order for the service and maintenance of SFCs for all cases filed in MDL. Brown Greer is a legal services firm specializing in mass claims administration and settlement administration services.

May 14, 2024: Judge Issues New Order Regarding Case Dismissals 

Plaintiffs in mass tort litigation often hire more than one lawyer for various reasons.  The MDL judge has received several motions to dismiss or stipulations of dismissal from plaintiffs due to duplicate cases filed by different law firms. Some of these requests seek dismissal with prejudice, while others seek dismissal without prejudice.

The judge said in a new order yesterday that there is no justification for dismissing a plaintiff’s case without prejudice when they are represented by competent counsel in another case. If that counsel becomes unable to represent the plaintiff, substitute counsel can step in. However, there will be no grounds to reinstate the previously dismissed case. Henceforth, all such dismissals will be with prejudice, regardless of the request made.

If you have hired more than one lawyer for your NEC lawsuit, you need to fix it. You are doing those lawyers, and more importantly, yourself, a disservice.  Tell everyone what happened and figure out who you want to bring your claim, and move forward.  Just make sure you do not dismiss a case that was filed within the statute of limitations for a case where there is some question about whether you missed the deadline.

November 1, 2023: MDL Judge Selects Four Key Bellwether Cases To Go To Trial 

U.S. District Judge Rebecca R. Pallmeyer in Illinois has selected four key “bellwether” cases to go to trial. These bellwether trials are intended to gauge potential jury reactions to the presented evidence. Of these four cases, two name both Abbott Laboratories (makers of Similac) and Mead Johnson (makers of Enfamil) as defendants, one names only Mead Johnson, and another solely names Abbott Laboratories. Three of these lawsuits are wrongful death claims attributed to NEC after consuming the formulas, with one detailing an infant who survived NEC but faced severe complications requiring multiple surgeries. These trials are anticipated to start by 2024, and their outcomes could will certainly influence NEC settlement payouts in this class action.

October 17, 2023: 275 Active Cases In NEC MDL 

Just 12 new cases were added to the NEC infant formula MDL (1:22-cv-00071) over the last month. That brings the total number of pending cases in the MDL up to 275. Over the last few months the new case volume had picked up somewhat, but now we are back to the slower pace that this MDL has experienced since it was created.

October 2, 2023: Judge Grants Plaintiffs Motion Seeking Extension Of Deadline For Selecting Bellwether Cases 

Following the most recent status conference in the NEC infant formula MDL, the Judge granted a motion by the plaintiffs seeking an extension of the deadline for selecting bellwether cases for the first round of test trials. The first bellwether trials could potentially happen late next year.

September 18, 2023: 263 Active Cases In NEC MDL  

83 new cases were added to the pre-term infant formula NEC class action MDL over the summer. There are now a total of 263 active cases in the MDL. At the start of the year there were only 97 cases, so this litigation is starting to build some momentum.

September 14, 2023: Court Orders Both Parties To Present Mutually Agreed Upon Discovery Timetable

Plaintiff lawyers in the NEC class action lawsuit are frustrated that the defendants have not conducted any treating doctor depositions. The treating doctors will be key witnesses in any failure to warn lawsuit.   But the defendants (Abbott and Mead) maintain that they’re prepared to make Bellwether Trial selections in a mere couple of weeks.

What’s behind all of this? The defendants want the first NEC jury trial to be in federal court, not state court even thought both competing jurisdictions are in Illinois.

So the plaintiff filed a motion asking the court to push back the bellwether selection date to December and to extend fact discovery until March 2024.

The court took the middle ground and ordered the parties to present a mutually agreed-upon order detailing the updated discovery timetable.  Then there will be another status conference to figure it all out.

August 21, 2023: Rowe v. Abbott Filed Directly Into MDL   

A new NEC wrongful death lawsuit – Rowe v. Abbott – was direct filed into the MDL class action (1:22-cv-00071) last week.  In this case, the child was born prematurely in 2007 in Maricopa County, Arizona.  He developed NEC after being given Abbott’s cow milk-based formula in the NICU. Tragically, he passed away after developing NEC.

As you see in every NEC baby formula lawsuit, the plaintiff – the child’s father – alleges that Abbott had a responsibility to provide clear warnings and guidelines for their cow-based milk products intended for preterm infants. The lawsuit alleges that these warnings should adequately inform healthcare providers and NICU staff about the product’s risks and proper use, considering the usual knowledge of such professionals. Specifically, they should have been alerted to the potential risks, including but not limited to the danger of NEC, associated with using these products with preterm infants.

August 17, 2023: 205 Active Cases In NEC MDL 

The NEC preemie formula class action has now doubled in size since the start of this year. 14 more cases were added last month, bringing the total number of pending cases up to 205. Assuming this growth rate continues, there will probably be around 300 cases by the end of the year and possibly 400 by the time we get to the first bellwether trials.

July 18, 2023: 191 Active Cases In NEC MDL  

11 new cases were transferred into the NEC infant formula class action MDL (1:22-cv-00071) over the last month. There are now a total of 191 cases pending in the MDL. At the start of the year there were only 90 pending cases.

July 11, 2023: Statute Of Limitations Expected To Be Battle In NEC Lawsuits 

The statute of limitations will be a battle in NEC lawsuits.  We should win this battle. But it will be a battle in some cases.

We are seeing this in NEC baby formula lawsuits in California state court where Judge Ethan P. Schulman of the San Francisco Superior Court “preliminarily approved” Abbott’s motion to dismiss sixteen lawsuits.  The judge is allowing the parents a chance to amend and refile their complaint, but that is only going to lead to a second battle.  Plaintiffs’ lawyers argue that the two-year period to submit their complaints should start only from when they discovered the alleged issues with the formula. This position is supported by both law and common sense notions of what justice looks like.

We will see how the court rules. In many of these cases, there is no statute of limitations question because state law allows the child to file suit until they are 18 or over.  But in some cases, an exception to the deadline to file is necessary, and that will lead to legal battles over whether the primary exception – the discovery rule applies.

July 1, 2023: Anonymous v. Mead Johnson 

An example of one of the more recent NEC infant formula lawsuits transferred into the MDL is the case of Anonymous v. Mead Johnson . The infant at issue in the case was born prematurely back in 2003.

Following his birth, Adam was given regular feedings with a cow milk-based Enfamil formula product. After a month of being fed with the formula, Adam was diagnosed with NEC. He had to undergo emergency surgery which left him with long-term health consequences.

His case was originally filed in federal court in Indiana and earlier this month transferred into the MDL NEC class action lawsuit.

May 31, 2023: Baby Formula Manufacturers Under Investigation By FTC 

A potential collusion in state contract bidding among baby formula manufacturers, including Abbott Laboratories, is currently under investigation by the U.S. Federal Trade Commission (FTC). This investigation was sparked in 2022 and is centered on bids for supplying the U.S. Department of Agriculture’s Women, Infants, and Children (WIC) program. The FTC is also seeking details about formula sales unrelated to the WIC program. This investigation takes place amidst a growing disagreement between the FTC and Abbott concerning the amount of information the company needs to disclose, following a shortage of formula due to Abbott’s plant closure in Michigan in February 2022 that we talk about below.

May 23, 2023: Federal Judge Dismisses Claims Of Economic Loss Regarding Allegedly Contaminated Similac 

Claims of economic loss lodged by parents who bought allegedly contaminated Similac infant formula have been dismissed by a federal judge in Illinois. The ruling was due to the fact that the plaintiffs did not establish that the specific formula they purchased was tainted by bacteria. Despite accusations that the formula by Abbott Laboratories caused severe illness in preterm infants, Judge Matthew Kennelly found that the plaintiffs could not prove they received anything other than what they paid for: a safe product. However, personal injury claims related to the children’s illnesses were not dismissed. The judge also reduced claims regarding unsanitary conditions at the production facility but maintained claims concerning the presence of heavy metals in the product.

This is probably a good development for NEC formula lawsuits. Why?  The NEC claims are what really matters. We are all better – lawyers on both sides – focusing on those claims.

May 1, 2023: Mead Refuses Deal With PLC For Additional 45 Custodians

E-discovery is crucial in litigation like this case.  Plaintiffs need to see the emails, business communications, and other data relevant to litigation that is almost always stored electronically in 2023. So companies’ custodians of records play a critical role in pretrial discovery.  Mead and Abbott are huge companies so there is a great deal of work to do.

Because mass tort litigation often involves intricate scientific and liability issues, courts typically set custodial caps exceeding 100 witnesses. In this case, the plaintiffs’ lawyers wanted 65 witnesses. Since the beginning of this NEC baby formula class action lawsuit, the lawyers have worked to ensure the timely completion of discovery, including obtaining electronic discovery (attorneys call it “ECI”) from Defendants’ employees. After months of negotiations, the PLC believed it had reached a deal with Defendants for an additional 45 custodians. Abbott agreed. Mead did not.

After refusing the global compromise, Mead proposed that its ESI custodial cap be limited to 22 additional custodians, with them selecting seven.  So plaintiffs’ attorneys have filed a motion to get the court’s help to deal with this problem

April 28, 2023: Bellwether Candidate Cases Now Undergoing Case-Specific Fact Discovery

The pool of 12 bellwether candidate cases in the NEC formula MDL are now going through case-specific fact discovery. These are the first NEC lawsuits that will go to trial.

This pretrial discovery process involves depositions of fact witnesses and doctors in each of the 12 lawsuits and it is intended to provide both sides with more information about the cases. Once this process is completed, four of the 12 cases will be selected for the actual bellwether trials which are set to being around this time next year.

March 8, 2023:   New Study Finds No Significant Difference In Incidence Of NEC Between Human Milk Diet And Bovine Milk Formula

A new study found no significant differences in the incidence of necrotizing enterocolitis between preterm infants who received an exclusive human milk diet and those who received bovine milk formula and fortifiers. The American Academy of Pediatrics has long recommended that preterm infants receive human milk, preferably their mother’s milk, and encourages the use of human milk fortifiers to provide additional nutrients to support growth and development.

So this study suggests providing newborns with human milk products not sourced from their mothers is just as efficient as using cow’s milk-based infant formula. This is all the more reason parents and hospitals should know some choices do not involve Similac and Enfamil that do not carry the same risk of NEC.

February 25, 2023: Five New NEC Cases Transferred Into MDL

Five new cases alleging that formula caused premature infants to develop NEC were transferred into the NEC formula class action MDL over the last month. The number of pending cases in the NEC formula MDL is now at 97. That is the same number of cases that were pending in July 2022. Why? For starters, many NEC formula cases are being litigated in state courts, which means they never get transferred into the MDL.

January 17, 2023: 97 Current Pending Cases In NEC MDL  

Nine new infant formula NEC cases were transferred into the class action lawsuit over the last month. This brings the total number of pending cases in the NEC formula MDL to 97. This litigation has no claims registry, so this total reflects all claims other than those brought in state court.

January 10, 2023: MDL Judge Attempts To Schedule A Science Day

The Judge in the NEC infant formula class action MDL in the Northern District of Illinois is attempted to schedule a “science day.”

Science days are a standard tool used in mass tort MDLs. They allow both sides to make presentations designed to educate the court on the pertinent scientific evidence. A date for the NEC infant formula science day is expected to be set at the January monthly status conference.

December 15, 2022: Bellwether Cases To Be Finalized By End Of Month 

By the end of this month, the group of 12 formula NEC cases that will participate in the bellwether program will be finalized. Eight of the cases have already been named, and the defense will select the last four next week.

On November 10th, the PLC submitted a proposed schedule for the bellwether program, setting a fact discovery deadline of April 2023. The proposed expert discovery deadline would be December 2023. The proposed schedule suggests that the first bellwether trials could begin in the spring of 2024. Four of the twelve bellwether program cases would be selected for trial and those selections would be made in May 2023.

November 11, 2022:  Eight Of Twelve Bellwether Cases Selected 

Eight infant formula NEC cases in the federal class action lawsuit have already been selected to take part in the bellwether program. Another four NEC lawsuits will be selected by the defendants by the end of the month.

Last week, the MDL judge issued a new Case Management Order formally approving a fact sheet questionnaire form that each of the twelve plaintiffs in these bellwether cases will be required to complete as the first step of the discovery process. That will be followed by depositions of the plaintiffs and then expert witness discovery.

November 7, 2022: 29 NEC Cases Remanded Back Down To Pennsylvania State Court 

The plaintiffs in 29 cases pending in the NEC infant formula MDL successfully moved to have their cases remanded back down to Pennsylvania state court earlier this month. All of these cases involved both product liability claims against the formula manufacturers, and tort claims against the local hospitals that fed the formula to the pre-term infants. These cases were subject to remand primarily because the inclusion of the local hospitals as defendants meant that the requirements for diversity jurisdiction in federal court were not met. The removal of these 29 NEC formula cases brings the total number of cases pending in the MDL down to 106.

October 9, 2022: Court To Randomly Select 12 Out Of Possible 66 Cases For Trial 

This week attorneys for victims and the formula companies in the Formula NEC class action MDL provided the judge with a list of 66 pending cases that the court could randomly choose to be the first NEC lawsuit to go to trial. The plaintiffs and defendants have each picked four cases. Four random lawsuits will be picked by the court will for the initial pool of 12 bellwether candidate cases. These 12 cases will go through pretrial discovery and then a group of four will be picked for trials. Each side will select two.

October 1, 2022: MDL Judge Issues Order Establishing Schedule And Protocol For Selection Of Bellwether Test Cases

The judge in the formula NEC class action lawsuit issued a significant order last month establishing the schedule and protocol for the selection of bellwether test cases.

First, a pool of 12 “bellwether discovery cases” will be selected. The plaintiffs will pick four of the cases. The defendants will also select four cases. The Court will randomly select the remaining four cases for this pool. This selection process will complete by November 23.

These 12 cases will then go through a short fact-discovery phase. Once this discovery is completed, four of the 12 cases will be picked for the initial bellwether test trials. The plaintiffs will pick two and the defendants will pick two. The four bellwether trials will then be held 12 weeks apart, alternating between cases selected by the plaintiffs and the defendants.

September 1, 2022: MDL Judge Drafts Plan Outlining Process For Bellwether Case Selection

Lawyers in the NEC infant formula class action have turned their eyes to the plan to choose which NEC lawsuit goes to trial first. The MDL judge now has a draft plan outlining a process for the selection of a pool of 12 cases for the opening round of bellwether test trials.

The lawyers will submit a list of 12 NEC lawsuits that could potentially be fully prepared for trial. This would involve even numbers of cases involving both Abbott and Mead Johnson together or as sole defendants. Once these 12 cases are selected, they will go through pretrial discovery, interrogatories, depositions, etc. After discovery is completed, each side will pick two NEC lawsuits out of the group of 12 for a total of four initial bellwether trials.

August 11, 2022: AAP Publishes Opinion Urging Parents To Avoid Infant Formula When Breast Milk Is A Viable Alternative 

The medical community continues to slide toward the plaintiffs’ view of baby formula for preemies. As the number of NEC lawsuits against formula manufacturers continues to rise, the American Academy of Pediatrics (AAP) published an updated opinion statement urging parents to avoid infant formula when human breast milk is an alternative.

The AAP is encouraging hospitals to stop allowing formula makers to promote their products in maternity wards, which is a huge step to solve this problem.

July 15, 2022: NEC MDL Nears 100 Active Cases

Only nine victims filed an NEC lawsuit that was transferred into the Preterm Infant Nutrition MDL over the last month. There are now 97 NEC baby formula class action lawsuits pending in federal court. Many NEC attorneys are still filing NEC formula lawsuits in state court in Illinois.

July 1, 2022: MDL Judge Indicated Intention To Allow Direct Filings

The judge in the federal NEC baby formula class action lawsuit has indicated that she wants to allow plaintiffs to file NEC formula lawsuits against Abbott and Mead Johnson directly in the MDL-3026. Previously, Judge Pallmeyer had been hesitant to permit direct filings which meant new plaintiffs had to file in their home district and have the case transferred into the MDL.

A proposed order allowing direct filings were issued earlier this week. Mead Johnson filed an objection to the proposed order. Which is nonsense. Even Abbott did not object.

June 17, 2022: 37 New Plaintiffs Added To NEC MDL Within Past Month 

Thirty-seven new plaintiffs were added in the first month of the newly formed preterm infant formula NEC MDL in the Northern District of Illinois (Abbott Laboratories Preterm Infant Nutrition Prod. Liab. Lit. – MDL No. 3026). This means that the size of the MDL doubled in the first 30 days. Our NEC formula lawyers expect to see an average of 30-60 new cases added to the MDL each month from now through the end of 2022. The pace of new lawsuits added to class action will likely slow down in 2023.

June 6, 2022: MDL Judge Issues CMO Finalizing Plaintiffs’ Lead Counsel, Liaison Counsel, And Steering Committee 

The federal baby formula class action lawsuit is moving forward. The judge in the newly formed Baby Formula NEC MDL (Hon. Rebecca R. Pallmeyer) recently issued a 2nd Case Management Order finalizing appointments of the Plaintiffs’ Lead Counsel, Liaison Counsel, and Steering Committee.

These NEC lawyers will act on behalf of all the plaintiffs involved in the NEC formula class action lawsuit moving forward. Meanwhile, the MDL continues to grow exponentially, with new cases being transferred from courts across the country. Since May 16th, an additional 26 new cases have been transferred. This brings the total number of pending NEC baby formula lawsuits in the class action up to 78.

May 23, 2022: NEC MDL Officially Underway 

The baby formula NEC class action lawsuit in the Northern District of Illinois (In re: Abbott Laboratories, et al., Preterm Infant Nutrition Prod. Liab. Lit.- MDL No. 3026) is officially underway. Judge Rebecca Pallmeyer has been assigned to the MDL class action. The judge held her opening status conference last week on May 19. Within the next two weeks, Judge Pallmeyer is expected to announce her selections for the plaintiffs’ lead counsel, Liaison Counsel, and leadership committee.

May 4, 2022: All NEC Litigations Continue To Move Forward

There are now three baby formula class action lawsuits. There is a baby formula NEC class action in federal court. Illinois state court also has roped off NEC lawsuits filed in that state from all over the country. We also have a Similac recall class action lawsuit that does not involve NEC. All three pieces of NEC litigation are moving forward.

April 11, 2022: Judge Rebecca R. Pallmeyer To Preside Over NEC MDL

We now have an NEC baby formula class action lawsuit in federal court. The JPML issued a transfer order which consolidates all pending NEC infant formula lawsuits into a new mass tort MDL: In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liab. Lit. (MDL No. 3026).

The NEC formula MDL has been assigned to Judge Rebecca R. Pallmeyer, Chief Judge of the Northern District of Illinois. Illinois was the venue preferred by the plaintiffs’ NEC baby formula lawyers. The defendants (Abbott and Mead Johnson) were ironically pushing to leave their home state and put in the MDL NEC class action in Connecticut. Now every NEC infant formula lawsuit in federal court will be transferred into the MDL for consolidated pretrial proceedings.

April 1, 2022: 40 NEC Lawsuits Filed In Federal Court Against Mead And Abbott Over The Last Year

Just over 40 NEC formula lawsuits have been filed against Mead and Abbott in federal courts over the last year. Twelve of these NEC lawsuits in federal court were filed in March 2022. As we discuss below, there is also a mini-class action NEC lawsuit in Illinois.

March 31, 2022: Abbott Seeks To Transfer Consolidated Cases From Madison County 

The Supreme Court of Illinois previously granted the request to consolidate a group of about 20 NEC formula cases pending in Illinois state courts before a single judge (Dennis Ruth) in Circuit Court for Madison County. This effectively created a mini-MDL NEC class action lawsuit at the state court level. Now, however, Abbott is seeking to have the consolidated cases transferred from Madison County to either Cook County (Chicago) or Lake County, under the doctrine of forum nonconveniens (inconvenient forum).

Why do you care about the Illinois baby formula lawsuits if you live in California, Texas, New York, or any other state outside of Illinois? Because many NEC baby formula lawsuits will file lawsuits in Illinois even if the claim arose in another jurisdiction.

March 1, 2022: NEC MDL To Be Housed In One Of Two States

It looks like an NEC baby formula class action lawsuit that will house all federal court NEC lawsuits is coming. The only question is whether the class action will be housed in Connecticut or Illinois.

Last week, Mead Johnson, the maker of Enfamil, advised the Judicial Panel on Multidistrict Litigation (JPML) that it was in favor of consolidating the NEC lawsuits into a new NEC MDL class action. In January 2022, Abbott, the manufacturer of Similac, filed a petition with the JPML requesting the formation of a new MDL for the consolidation of all NEC infant formula lawsuits in the federal courts.

Abbott’s attorneys are requesting the District of Connecticut, while lawyers for NEC plaintiffs’ lawyers favor the Northern District of Illinois where Abbott is headquartered.

February 20, 2022: FDA Announces Massive Similac Recall

As if Abbott did not have enough problems with Similac in the NEC lawsuits, the FDA announced a massive Similac recall impacting thousands of children.

February 11, 2022: Consumer Protection Groups File Petition Requesting FDA To Ban Certain Additive In Infant Formula

As pressure from NEC lawsuits continues to grow, baby formula manufacturers face a new challenge. Two consumer protection groups filed a petition last week asking the FDA to ban the use of certain additives in infant formula. The petition seeks to prevent companies like Abbott and Mead Johnson from using additives (known as nanomaterials) in their products because of the potential health impact of these ingredients.

February 1, 2022: NEC Lawsuits Expected To Be Consolidated Into Single Action In Madison County 

In December, NEC baby formula lawyers filed a motion asking the Supreme Court of Illinois to consolidate all pending preemie NEC infant formula lawsuits in the state into a single action in Madison County.

The court granted motions by defendants Abbott and Mead Johnson for an extension of time to respond until this month to respond to the consolidation request. Will Mead and Abbott ultimately oppose the request? Both companies are based in the Chicago area. Combining the Illinois cases into a single consolidated action would be much more efficient than defending potentially hundreds of NEC baby formula lawsuits separately.

Why so much interest in the Illinois NEC cases? Many attorneys plan to file all their NEC Similac and Enfamil baby formula lawsuits in Illinois. So if you are in New York, California, Texas, or anywhere in the U.S., your NEC lawsuit might be filed in Illinois.

December 18, 2021: NEC Lawsuits Spike In Illinois State Court

A large number of infant formula NEC lawsuits are being filed in Illinois state court. Illinois has become a common venue for NEC lawsuits because Abbott Laboratories and Mead Johnson are headquartered in Chicago. This week, lawyers for some of the plaintiffs in these state court NEC lawsuits filed a motion with the Supreme Court of Illinois, requesting that the court consolidate the NEC cases before a single judge for coordinated pretrial proceedings. This is the Illinois state court equivalent of an MDL request.

The motion identified 33 NEC infant formula lawsuits currently pending in Illinois civil courts (31 in Madison County). All 33 of these NEC cases were filed in the last 10 months, indicating the growing momentum behind the NEC formula litigation. Consolidation of these cases in Illinois could be followed by the creation of a national baby formula MDL for NEC lawsuits in federal court. This could help clear a path toward an eventual global NEC settlement for most or all these claims.

December 10, 2021: New Study Further Confirms Link Between Cow-Milk-Based Formula And Risk Of NEC

A new study published last month further confirms that feeding cow-milk-based formula to premature infants dangerously increases their risk of NEC while also slowing their development. A research team from McMaster University in Ontario published their findings in the journal Pediatrics and Child. The study found that when premature babies are fed infant formula instead of breast milk, newborn preemies are three times more likely to develop NEC and be sent to the NICU.